Page last updated: 2024-12-07
hexylphosphonic acid diethyl ester
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 85311 |
| SCHEMBL ID | 2150291 |
| MeSH ID | M0129448 |
Synonyms (18)
| Synonym |
|---|
| diethyl hexylphosphonate |
| brn 1771540 |
| pae(sub 6) |
| hexylphosphonic acid diethyl ester |
| phosphonic acid, hexyl-, diethyl ester |
| ai3-18566 |
| 1-diethoxyphosphorylhexane |
| 4-04-00-03560 (beilstein handbook reference) |
| hexane phosphonic acid diethyl ester |
| 16165-66-5 |
| SCHEMBL2150291 |
| AKOS017343265 |
| VVUJWLDQIIFQHI-UHFFFAOYSA-N |
| DTXSID60167209 |
| diethyl (1-hexyl)phosphonate |
| mfcd00015140 |
| phosphonic acid, p-hexyl-, diethyl ester |
| hexyl-phosphonic acid diethyl ester |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effects of the factors, such as PC concentration, substrate ratio, water amount, lipase dosage and temperature, on the oleic acid content in PC and PC recovery during the interesterification were investigated." | ( Increase of Oleic Acid Content in Phosphatidylcholine through Lipase-catalyzed Interesterification: Optimization by Response Surface Methodology. Yang, G; Yang, L, 2015) | 0.42 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.85
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.85) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||